CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-11-17 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +67,308 | 670,519 | ||
| 2010-06-02 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +3,125,000 | 7,091,477 | ||
| 2010-06-02 | FORBES CHRISTOPHER Director | Purchase · Series B Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 1,000 |
| 2010-05-25 | FORBES CHRISTOPHER Director | Grant or award | +182,840 | $0.37 | $67K | 3,227,020 |
| 2010-05-25 | FORBES CHRISTOPHER Director | Grant or award | +78,469 | $0.51 | $40K | 3,305,489 |
| 2010-05-25 | FORBES CHRISTOPHER Director | Conversion | +4,101,800 | $0.83 | $3.4M | 7,407,289 |
| 2010-05-25 | FORBES CHRISTOPHER Director | Exercise or conversion · Convertible Debenture Due 12/31/2010 | −0 | $0.83 | $0 | 0 |
| 2010-05-20 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +19,262 | 478,211 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +54,166 | 458,949 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +510,676 | 1,129,399 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +851,123 | 1,980,522 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +567,416 | 2,547,938 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +851,123 | 3,399,061 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +567,416 | 3,966,477 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Convertible Debenture Due 12/31/2010 | +0 | 15,156,574 | ||
| 2009-11-19 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +48,718 | 364,783 | ||
| 2009-11-19 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +40,000 | 404,783 | ||
| 2009-07-29 | FORBES CHRISTOPHER Director | Purchase | +97,778 | $0.90 | $88K | 2,191,799 |
| 2009-07-29 | FORBES CHRISTOPHER Director | Purchase | +88,000 | 529,501 | ||
| 2009-07-29 | FORBES CHRISTOPHER Director | Purchase | +89,222 | 618,723 |
Page 2 of 3 · 59 trades